Therapeutic effects of PKC activators in Alzheimer's disease transgenic miceRené Etcheberrigaray, Daniel L. Alkon, Mathew Tan et al.|Proceedings of the National Academy of Sciences|2004Cited by 339
A ketogenic diet reduces amyloid beta 40 and 42 in a mouse model of Alzheimer's diseaseIngrid Van der Auwera, Samuel T. Henderson, Stefaan Wera et al.|Nutrition & Metabolism|2005Cited by 314
Liposomal vaccines with conformation-specific amyloid peptide antigens define immune response and efficacy in APP transgenic miceAndreas Muhs, Claude Nicolau, Valérie Giriens et al.|Proceedings of the National Academy of Sciences|2007Cited by 176
Generation and Therapeutic Efficacy of Highly Oligomer-Specific β-Amyloid AntibodiesHeinz Hillen, Ulrich Ebert, Stefan Barghorn et al.|Journal of Neuroscience|2010Cited by 113
Neuronal or Glial Expression of Human Apolipoprotein E4 Affects Parenchymal and Vascular Amyloid Pathology Differentially in Different Brain Regions of Double- and Triple-Transgenic MiceTom Van Dooren, Fred Van Leuven, David Muyllaert et al.|American Journal Of Pathology|2006Cited by 34